Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Fish Dis ; 40(2): 219-229, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27416895

RESUMO

We report the first description of a new Rhabdoviridae tentatively named eelpout rhabdovirus (EpRV genus Perhabdovirus). This virus was associated with mass mortalities in eelpout (Zoarces viviparous, Linnaeus) along the Swedish Baltic Sea coast line in 2014. Diseased fish showed signs of central nervous system infection, and brain lesions were confirmed by histology. A cytopathogenic effect was observed in cell culture, but ELISAs for the epizootic piscine viral haemorrhagic septicaemia virus (VHSV), infectious pancreas necrosis virus (IPNV), infectious haematopoietic necrosis virus (IHNV) and spring viraemia of carp virus (SVCV) were negative. Further investigations by chloroform inactivation, indirect fluorescence antibody test and electron microscopy indicated the presence of a rhabdovirus. By deep sequencing of original tissue suspension and infected cell culture supernatant, the full viral genome was assembled and we confirmed the presence of a rhabdovirus with 59.5% nucleotide similarity to the closest relative Siniperca chuatsi rhabdovirus. The full-genome sequence of this new virus, eelpout rhabdovirus (EpRV), has been deposited in GenBank under accession number KR612230. An RT-PCR based on the L-gene sequence confirmed the presence of EpRV in sick/dead eelpout, but the virus was not found in control fish. Additional investigations to characterize the pathogenicity of EpRV are planned.


Assuntos
Doenças dos Peixes/virologia , Genoma Viral , Perciformes , Infecções por Rhabdoviridae/veterinária , Rhabdoviridae/fisiologia , Animais , Sistema Nervoso Central/virologia , Filogenia , Rhabdoviridae/genética , Infecções por Rhabdoviridae/virologia , Análise de Sequência de RNA/veterinária , Suécia
2.
Rev Sci Tech ; 34(2): 453-66, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26601448

RESUMO

Tick-borne encephalitis (TBE), a zoonotic arbovirosis caused by tick-borne encephalitis virus (TBEV), is an increasing public health concern. Infections result in neurological symptoms in humans and the virus has rapidly expanded to new geographical areas. Three subtypes are currently present in different parts of Europe and Asia. The virus is transmitted by ticks, mainly Ixodes spp., between small mammals such as rodents, which serve as virus amplifying hosts. Humans are infected sporadically, either by a tick bite or by ingestion of infected milk or milk products. Other mammals (e.g. ruminants) can also be infected, but most of the time do not show clinical signs. In contrast to rodents, other wild and domestic mammals probably play only a very small direct role in maintaining TBEV in an area, but they might play an important role as hosts in sustaining a large tick population. Therefore, the virus prevalence and the occurrence of TBE can be influenced by several environmental, genetic and behavioural factors associated with the virus, the vectors or the hosts, and understanding these factors is essential for implementation of effective control measures. This article reviews virus characteristics and the epidemiological and clinical aspects of TBEV infections and examines pathogenesis, diagnostic approaches and control measures.


Assuntos
Vírus da Encefalite Transmitidos por Carrapatos/genética , Encefalite Transmitida por Carrapatos/virologia , Animais , Encefalite Transmitida por Carrapatos/epidemiologia , Variação Genética , Humanos , Filogenia
3.
Euro Surveill ; 16(14)2011 Apr 07.
Artigo em Inglês | MEDLINE | ID: mdl-21492529

RESUMO

Surveillance for the fox tapeworm, Echinococcus multilocularis, has been carried out in Sweden since 2000, with about 300 red foxes analysed annually. We report the first finding of E. multilocularis in Sweden, in a fox shot in December 2010 in the south-west of the country. A second infected fox shot in the same location was detected in March 2011. This paper describes the national monitoring programme and the ongoing work to estimate the prevalence and spread of the infection.


Assuntos
Equinococose/veterinária , Echinococcus multilocularis/isolamento & purificação , Raposas/parasitologia , Animais , Clima , DNA de Helmintos/análise , Equinococose/epidemiologia , Equinococose/parasitologia , Fezes/parasitologia , Feminino , Enteropatias Parasitárias/parasitologia , Enteropatias Parasitárias/veterinária , Reação em Cadeia da Polimerase , Vigilância da População , Estações do Ano , Suécia/epidemiologia
4.
Allergy ; 61(9): 1063-70, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16918508

RESUMO

BACKGROUND: Basophils are inflammatory cells associated with allergy and parasite infections. Investigation of their true biological function has long been hampered by the difficulty in obtaining sufficient amounts of pure basophils and by the lack of phenotypic markers. Moreover, it has been very difficult to clone and identify basophil-specific granule proteins, partially because of an almost complete lack of mRNA in mature circulating basophils. METHODS: To obtain transcriptionally active immature basophils, umbilical cord blood cells were cultured in the presence of interleukin (IL)-3. The cells were analysed by flow cytometry and by histological staining. RESULTS: The continuous presence of IL-3 in cord blood cultures resulted in the expansion of basophil precursors co-expressing FcepsilonRI and the recently described mast cell/basophil marker, 97A6 (CD203c). Several nonbasophil markers (i.e. CD3, CD14, CD15, CD16, CD19 and CD21) were absent on the cultured basophils. However, we show that in early cultures, almost 60% of the CD203c+ cells co-express human leukocyte antigen (HLA)-DR, a marker that is absent on mature circulating basophils. The presence of HLA-DR on basophil precursors may explain the low recovery (24+/-5.2%) obtained after isolation of cultured basophils, when using a conventional basophil isolation kit that removes HLA-DR+ cells. A novel purification method was developed, including a two-step cocktail of antibodies against selected markers, which resulted in both high purity (95+/-0.5%) and recovery (59+/-1.5%) of cultured basophils. CONCLUSIONS: We here establish cord blood cultures as a source from which transcriptionally active basophil precursors can be isolated in reasonable quantities for thorough biochemical characterization.


Assuntos
Basófilos/imunologia , Basófilos/metabolismo , Sangue Fetal/citologia , Sangue Fetal/imunologia , Antígenos HLA-DR/genética , Diester Fosfórico Hidrolases/genética , Pirofosfatases/genética , Receptores de IgE/biossíntese , Receptores de IgE/genética , Separação Celular , Células Cultivadas , Sangue Fetal/metabolismo , Antígenos HLA-DR/biossíntese , Humanos , Diester Fosfórico Hidrolases/biossíntese , Pirofosfatases/biossíntese , Células-Tronco/imunologia , Células-Tronco/metabolismo , Ativação Transcricional/imunologia , Veias Umbilicais
5.
Clin Exp Allergy ; 35(6): 708-12, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15969658

RESUMO

BACKGROUND: Mast cells (MCs) accumulate at sites of allergic mucosal inflammation where they act as central effectors and regulatory cells. Chemokines are believed to be crucial for the recruitment of MCs to sites of inflammation. We recently reported that human umbilical cord blood MCs (CBMCs) expresses the CC chemokine receptors, CCR1 and CCR4. We found a unique response profile to ligands of the respective receptors in which, of all tested ligands, only CCL5/RANTES-induced migration. OBJECTIVE: To further investigate the function of CCR4 in MCs. METHODS: CBMCs were used for competition binding experiments, migration, and intracellular calcium mobilization and release response studies. RESULTS: The natural ligands for CCR4, CCL17/TARC and CCL22/MDC could both compete for binding with radiolabelled CCL5. Further, both CCL17 and CCL22 act as CCR4 antagonists by inhibiting CCL5-induced migration. Although both CCL17 and CCL22 caused mobilization of intracellular calcium, none of them induced migration or histamine release. CONCLUSIONS: These results suggest that CCL5-induced migration of MCs via CCR4 can be regulated by the natural agonists CCL17 and CCL22, which are up-regulated at sites of allergic inflammation.


Assuntos
Quimiocinas CC/fisiologia , Mastócitos/fisiologia , Cálcio/metabolismo , Movimento Celular/fisiologia , Células Cultivadas , Quimiocina CCL17 , Quimiocina CCL22 , Quimiocina CCL5 , Quimiocina CXCL10 , Quimiocinas CXC/fisiologia , Sangue Fetal/citologia , Histamina/metabolismo , Humanos , Macrófagos/fisiologia , Receptores CCR4 , Receptores de Quimiocinas/fisiologia
6.
Leukemia ; 17(1): 203-10, 2003 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-12529679

RESUMO

Multiple myeloma (MM) is a B cell tumor characterized by its selective localization in the bone marrow. The mechanisms that contribute to the multiple myeloma cell recruitment to the bone marrow microenvironment are not well understood. Chemokines play a central role for lymphocyte trafficking and homing. In this study we have investigated expression and functional importance of chemokine receptors in MM-derived cell lines and primary MM cells. We found that MM cell lines express functional CCR1, CXCR3 and CXCR4 receptors, and some also CCR6. Although only a minority of the cell lines responded by calcium mobilization after agonist stimulation, a migratory response to the CCR1 ligands RANTES and MIP-1 alpha was obtained in 5/6 and 4/6, respectively, of the cell lines tested. Five out of six cell lines showed a response to the CXCR4 ligand SDF-1. In addition, 3/6 cell lines migrated in response to MIP-3 alpha and IP-10, ligands for CCR6 and CXCR3, respectively. The expression of CXCR4 and CCR1 and the migration to their ligands, SDF-1, and RANTES and MIP-1 alpha, respectively, were also demonstrated in primary MM cells. These findings suggest that chemokine receptor expression and the migratory capacity of MM cells to their ligands are relevant for the compartmentalization of MM cells in the bone marrow.


Assuntos
Mieloma Múltiplo/metabolismo , Receptores de Quimiocinas/metabolismo , Cálcio/metabolismo , Movimento Celular/efeitos dos fármacos , Quimiocina CCL4 , Quimiocina CCL5/farmacologia , Quimiocina CXCL12 , Quimiocinas CXC/farmacologia , Quimiotaxia , Humanos , Proteínas Inflamatórias de Macrófagos/farmacologia , Mieloma Múltiplo/patologia , Receptores de Quimiocinas/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Ribonuclease Pancreático/metabolismo , Células Estromais , Células Tumorais Cultivadas/efeitos dos fármacos , Células Tumorais Cultivadas/metabolismo
7.
Eur J Immunol ; 30(12): 3614-22, 2000 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11169404

RESUMO

In this study we provide evidence that the chemokine stromal cell-derived factor-1alpha (SDF-1alpha) acts as a mast cell chemoattractant through interactions with its receptor CXCR4 expressed on mast cell progenitors in the blood as well as on in vitro-developed and leukemic mast cells. We found expression of CXCR4 on cord blood-derived mast cells (CBMC) and on the human mast cell line HMC-1, analyzed by RNAse protection assay and flow cytometry. SDF-1alpha induced intracellular calcium mobilization in HMC-1 cells and was chemotactic for both HMC-1 cells and CBMC. The activity of SDF-1alpha was completely blocked by treating the cells with pertussis toxin, indicating the involvement of Gi-proteins in the signaling. By applying a transwell assay we could show that SDF-1alpha induces migration of a cell population in peripheral blood that is enriched for cells with the capacity to differentiate into mast cells. These findings thus suggest a mechanism by which human mast cell progenitors may be recruited from circulation into the tissue.


Assuntos
Quimiocinas CXC/farmacologia , Fatores Quimiotáticos/farmacologia , Mastócitos/química , Receptores CXCR4/análise , Cálcio/metabolismo , Movimento Celular/efeitos dos fármacos , Quimiocina CXCL12 , Humanos , Mastócitos/fisiologia , Proteínas Oncogênicas/análise , Proteínas Proto-Oncogênicas c-kit , Fator de Células-Tronco/farmacologia , Células-Tronco/efeitos dos fármacos , Células-Tronco/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...